If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 29.00
Low: 28.50
Prev. Close: 28.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2024 Conference Schedule

15 Jan 2024 07:00

RNS Number : 6021Z
Ilika plc
15 January 2024
 

Ilika plc

("Ilika" or the "Company")

 

 

2024 Conference Schedule

 

Ilika to Attend Major Global Events to Promote Stereax® and Goliath Progress

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces its conference and trade show schedule for the first half of 2024 - with the team attending several major MedTech and Automotive conferences. At each event Ilika representatives will either give a presentation, chair a session, form part of a panel or be available at a booth, enabling thought-leadership exchange and engagement with key industry peers and prospective business partners.

 

Ilika will use the MedTech conferences to further promote its developing relationship with Cirtec Medical and to provide updates on its ten-year manufacturing licence to produce the Stereax range of mm-scale batteries at Cirtec's facility. The Company will use its attendance at Automotive conferences to raise the profile of its programme to manufacture and test batches of Goliath pouch cells as development continues to target delivery of fully characterised cells to its customers.

 

Medical Devices Conferences

 

North American Neuromodulation Society (NANS) Annual Meeting

For the first time, Ilika and Cirtec Medical will be sharing a booth (#505) to jointly promote Stereax miniature solid state batteries at the 2024 NANS Annual Meeting, on January 18-21 in Las Vegas, USA.

 

Medical Device and Manufacturing (MD&M) West

MD&M will be held on February 6-8 in Anaheim, USA where Ilika will give a presentation to the Medical Battery Conference section of the show, discussing the potential benefits Stereax solid state batteries can deliver in miniaturisation and active implanted medical devices.

 

Automotive and Electric Vehicle Conferences

 

International Battery Seminar (IBS)

At IBS, March 12-15 in Orlando, USA, Ilika's Product Manager, Dr Denis Pasero, will chair the "Solid State Battery Program Update" session.

 

Battery Tech Expo

At Battery Tech Expo, April 25 in Silverstone, UK, Ilika will provide an update on its progress developing the first Goliath solid state battery product and its activity securing the scale-up of its technology.

 

MOVE 2024

CEO Graeme Purdy will join a panel to discuss solid state batteries for transportation at MOVE 2024, on June 19-20 in London. Ilika will use the event to network and identify trends emerging from other prestigious shows in the calendar.

 

Graeme Purdy, Ilika CEO stated: "This is an exciting year for Ilika with both our Goliath and Stereax solid state batteries moving forward in line with our roadmap. Last year, we finalised our partnership with Cirtec Medical to manufacture and commercialise our Stereax mm-scale batteries, and we achieved our D4 development point and lithium-ion energy density parity with our Goliath technology for electric vehicles. As we continue with our roadmap this year, we'll be presenting updates at key worldwide events, showing how our technology can transform both the EV and the MedTech markets."

 

For more information contact:

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive Officer

Via Walbrook PR

Jason Stewart, Chief Financial Officer

Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,

Nikhil Varghese

Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,

Mara Grasso

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Nick Rome, Charlotte Edgar, Joe Walker

 

About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFDFWEELSEEF
Date   Source Headline
23rd Apr 20122:44 pmRNSHolding(s) in Company
23rd Apr 20128:01 amRNSDirector/PDMR Shareholding
20th Apr 201212:49 pmRNSGeneral Meeting Results
4th Apr 201212:26 pmRNSPosting of circular
4th Apr 20127:00 amRNSPlacing and Subscription
13th Mar 20127:00 amRNSContract Renewals and Trading Update
2nd Feb 20127:00 amRNSJoint Development agreement with Energizer
10th Jan 20127:00 amRNSHalf Yearly Report
9th Jan 20127:00 amRNSNew contract with Toshiba
6th Dec 20117:00 amRNSAltrika grant award and new JDP
28th Nov 20117:00 amRNSSolid State Battery Development
16th Nov 20117:00 amRNSTrading Update
29th Sep 20118:21 amRNSFirst US electronics contract / Expansion in Asia
13th Sep 20115:06 pmRNSResult of AGM
2nd Aug 20117:00 amRNSPosting of annual report
14th Jul 20117:00 amRNSFull Year Results
4th May 20117:00 amRNSTrading Update
18th Apr 20117:00 amRNSCarbon Trust Grant / New Customer Contract
4th Mar 20118:00 amRNSRenewal of Contracts
24th Feb 20112:56 pmRNSNotification of Interest
23rd Feb 201112:16 pmRNSNotification of Interest
19th Jan 20113:00 pmRNSDISTRIBUTION OF INTERIM ACCOUNTS FOR 2010
24th Nov 20107:00 amRNSInterim Results
29th Oct 20107:00 amRNSIlika awarded Carbon Trust R&D Grant
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
20th Oct 20104:35 pmRNSAnnual Financial Report
20th Oct 20104:35 pmRNSAnnual Financial Report
8th Oct 201010:30 amRNSInternational Business Development Appointments
8th Sep 20107:00 amRNSRevenue Update and Contract Renewal
18th Aug 20104:13 pmRNSNotification of Interest
17th Aug 20107:00 amRNSTotal Voting Rights
5th Aug 20104:05 pmRNSHolding(s) in Company
28th Jul 20107:00 amRNSUK Government Grant for Skin Wound Treatment
15th Jul 20107:00 amRNSFuel Cell Materials Joint Development Project
15th Jul 20107:00 amRNSFinal Results
30th Jun 20107:00 amRNSDevelopment Project
16th Jun 20107:00 amRNSFuel cell catalyst scale-up agreement
10th Jun 201012:39 pmRNSInspection, Regulatory Authority for Skin Products
9th Jun 20109:25 amRNSIlika partners to develop business in China
2nd Jun 20104:25 pmRNSExercise of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20108:02 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.